# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 08-12-2024 | 06-30-2024 | 10-Q | |
2 | 05-09-2024 | 03-31-2024 | 10-Q | |
3 | 03-15-2024 | 12-31-2023 | 10-K | |
4 | 11-14-2023 | 09-30-2023 | 10-Q | |
5 | 08-14-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New investigational new drug (IND) application cleared to proceed by the US FDA for a Phase 1/2 clinical study of ATR-04 for mo...
Anitra (AMEX:AZTR) reported quarterly losses of $(2.74) per share which missed the analyst consensus estimate of $(0.36) by 661...